Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| 10-K | 10-K | 10-K | 10-K | 10-K |
Net revenue | 2,970.6 | 2,454.5 | 1,056.4 | 529.6 | 345.3 |
Net revenue growth | 21.0% | 132.4% | 99.5% | 53.4% | |
Revenue, Product and Service [Extensible Enumeration] | | | | | |
Costs and expenses: | | | | | |
Cost of net revenue | 2,553.2 | 2,008.9 | 898.6 | 440.7 | 293.4 |
|
Cost, Product and Service [Extensible Enumeration] | | | | | |
General and administrative expenses | 162.1 | 167.5 | 89.3 | 56.5 | 18.1 |
Depreciation and amortization, excluding patient equipment depreciation | 64.9 | 63.1 | 11.4 | 3.1 | |
Total costs and expenses | 5,846.2 | 4,731.2 | 2,142.9 | 1,099.9 | 682.2 |
Operating income | 190.4 | 225.6 | 71.3 | 29.4 | 31.1 |
Operating margin | 6.4% | 9.2% | 6.8% | 5.5% | 9.0% |
Interest expense, net | -109.4 | -95.2 | -41.4 | -39.3 | -7.5 |
Change in fair value of warrant liability (note 10) | -17.2 | -53.2 | 135.4 | 7.7 | |
Other loss, net | 0.3 | 1.8 | -3.4 | -0.3 | |
Income before income taxes | 97.9 | 191.0 | -206.0 | -21.9 | 22.2 |
Income tax expense | 24.8 | 32.8 | -12.0 | 0.7 | -2.1 |
Net income | 73.1 | 158.2 | -194.1 | -22.6 | 24.3 |
Income attributable to noncontrolling interest | 3.8 | 2.0 | -32.5 | -1.3 | 1.1 |
Net income attributable to AdaptHealth Corp. | 69.3 | 156.2 | -161.6 | -21.3 | 23.3 |
|
Weighted average common shares outstanding - basic (in shares) | 134.2 | 126.3 | 52.5 | 22.6 | 11.9 |
Weighted average common shares outstanding - diluted (in shares) | 139.0 | 133.0 | 52.5 | 22.6 | |
|
Basic net income per share (note 11) (in dollars per share) | $0.47 | $1.12 | ($3.08) | ($0.95) | $1.95 |
Diluted net income per share (note 11) (in dollars per share) | $0.33 | $0.67 | ($3.08) | ($0.95) | $1.95 |
|